Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, DryShips Inc., ImmunoCellular Therapeutics, Ltd., KBR, Inc., Sunesis Pharmaceuticals, Inc., Sunrun Inc. and Vince Holding Corp.

IMUC, RUN, VIRX, KBR, VNCE

PR Newswire

NEW YORK, May 15, 2017 /PRNewswire/ --

Anadarko Petroleum Corporation (APC)

Lifshitz & Miller announces investigation on behalf of APC investors concerning whether APC failed to maintain adequate safety protocols in connection with certain of its vertical wells, leading to an increased risk of an explosion.

If you are an APC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

DryShips Inc. (DRYS)

Lifshitz & Miller announces investigation on behalf of DRYS investors concerning whether DRYS issued false and misleading statements about its business, operations and prospects causing its share price to peak at soar between November 9 and November 16, 2016 from $163 to $2,336 per share. After DRYS' price peaked, DRYS engaged in a series of stock sales totaling more than $500 million and shares have fallen over 99% in price.

If you are an DRYS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ImmunoCellular Therapeutics, Ltd. (IMUC)

Lifshitz & Miller announces investigation on behalf of IMUC investors concerning whether IMUC engaged in an illegal stock promotion scheme by paying for Lidingo Holdings, LLC to publish positive articles promoting IMUC's clinical studies of ICT-107.

If you are an IMUC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

KBR, Inc. (KBR)

Lifshitz & Miller announces investigation on behalf of KBR investors concerning whether a KBR subsidiary violated applicable bribery and corruption laws in the United Kingdom.

If you are a KBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Sunesis Pharmaceuticals, Inc. (SNSS)

Lifshitz & Miller announces investigation on behalf of SNSS investors concerning whether SNSS failed to adequately disclose the suitability of its treatment vosaroxin for approval in Europe.

If you are an SNSS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Sunrun Inc. (RUN)

Lifshitz & Miller announces investigation on behalf of RUN investors concerning whether RUN failed to accurately disclose how many customers cancelled contracts after signing up for RUN's home-solar energy system.

If you are a RUN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Vince Holding Corp. (VNCE)

Lifshitz & Miller announces investigation on behalf of VNCE investors concerning whether VNCE failed to disclose it experienced issues related to integrating its new enterprise resource planning systems.

If you are a VNCE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq. 
Lifshitz & Miller LLP
Phone:  516-493-9780
  
Facsimile: 516-280-7376 
Email: info@jlclasslaw.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-anadarko-petroleum-corporation-dryships-inc-immunocellular-therapeutics-ltd-kbr-inc-sunesis-pharmaceuticals-inc-sunrun-inc-and-vince-holding-corp-300457983.html

SOURCE Lifshitz & Miller Law Firm



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today